PolyPid (PYPD) Competitors $3.43 -0.06 (-1.72%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$3.37 -0.06 (-1.78%) As of 08/14/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PYPD vs. LAKE, INFU, AVR, BSGM, LUCD, ICAD, OBIO, ZJYL, MBOT, and FONRShould you be buying PolyPid stock or one of its competitors? The main competitors of PolyPid include Lakeland Industries (LAKE), InfuSystem (INFU), Anteris Technologies Global (AVR), Biosig Technologies (BSGM), Lucid Diagnostics (LUCD), icad (ICAD), Orchestra BioMed (OBIO), Jin Medical International (ZJYL), Microbot Medical (MBOT), and Fonar (FONR). These companies are all part of the "medical equipment" industry. PolyPid vs. Its Competitors Lakeland Industries InfuSystem Anteris Technologies Global Biosig Technologies Lucid Diagnostics icad Orchestra BioMed Jin Medical International Microbot Medical Fonar PolyPid (NASDAQ:PYPD) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations. Which has more risk and volatility, PYPD or LAKE? PolyPid has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Do analysts prefer PYPD or LAKE? PolyPid currently has a consensus price target of $12.40, indicating a potential upside of 261.52%. Lakeland Industries has a consensus price target of $26.00, indicating a potential upside of 73.56%. Given PolyPid's stronger consensus rating and higher possible upside, analysts plainly believe PolyPid is more favorable than Lakeland Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PolyPid 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17Lakeland Industries 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in PYPD or LAKE? 26.5% of PolyPid shares are held by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are held by institutional investors. 24.7% of PolyPid shares are held by company insiders. Comparatively, 1.9% of Lakeland Industries shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer PYPD or LAKE? In the previous week, PolyPid had 17 more articles in the media than Lakeland Industries. MarketBeat recorded 19 mentions for PolyPid and 2 mentions for Lakeland Industries. Lakeland Industries' average media sentiment score of 1.82 beat PolyPid's score of 0.39 indicating that Lakeland Industries is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PolyPid 4 Very Positive mention(s) 0 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lakeland Industries 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has stronger earnings & valuation, PYPD or LAKE? Lakeland Industries has higher revenue and earnings than PolyPid. Lakeland Industries is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolyPidN/AN/A-$29.02M-$4.30-0.80Lakeland Industries$167.21M0.85-$18.08M-$3.01-4.98 Is PYPD or LAKE more profitable? PolyPid has a net margin of 0.00% compared to Lakeland Industries' net margin of -13.31%. Lakeland Industries' return on equity of -6.88% beat PolyPid's return on equity.Company Net Margins Return on Equity Return on Assets PolyPidN/A -1,042.66% -167.87% Lakeland Industries -13.31%-6.88%-4.47% SummaryPolyPid beats Lakeland Industries on 9 of the 16 factors compared between the two stocks. Get PolyPid News Delivered to You Automatically Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYPD vs. The Competition Export to ExcelMetricPolyPidMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$55.48M$2.48B$5.61B$9.84BDividend YieldN/A1.76%4.61%4.07%P/E Ratio-0.9022.0530.2925.74Price / SalesN/A742.42463.41115.83Price / CashN/A184.4138.2159.48Price / Book4.574.838.826.15Net Income-$29.02M$31.61M$3.25B$265.06M7 Day Performance6.52%4.55%3.70%2.60%1 Month Performance-2.00%5.69%5.84%2.83%1 Year Performance-4.99%12.71%29.92%25.58% PolyPid Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYPDPolyPid3.0334 of 5 stars$3.43-1.7%$12.40+261.5%-1.7%$55.48MN/A-0.9080Trending NewsEarnings ReportAnalyst ForecastShort Interest ↓LAKELakeland Industries4.7875 of 5 stars$13.90+1.0%$26.00+87.1%-34.8%$132.21M$177.65M-4.622,100INFUInfuSystem3.5829 of 5 stars$5.98+2.1%$12.50+109.2%N/A$125.36M$137.58M99.43410AVRAnteris Technologies GlobalN/A$3.42-0.3%$16.50+382.5%N/A$123.33M$2.49M0.00138News CoverageEarnings ReportBSGMBiosig Technologies2.3744 of 5 stars$4.13-6.9%$10.00+142.4%+900.0%$113.84M$40K0.0050News CoverageLUCDLucid Diagnostics1.9319 of 5 stars$1.01-1.5%$3.55+253.2%+19.0%$108.73M$4.35M-0.7570Trending NewsAnalyst ForecastICADicad0.584 of 5 stars$3.87flatN/AN/A$106.31M$19.61M-20.37140OBIOOrchestra BioMed3.3926 of 5 stars$2.64-1.7%$14.00+431.3%-52.0%$102.28M$2.64M-1.494Earnings ReportAnalyst ForecastZJYLJin Medical InternationalN/A$0.65+0.7%N/A-81.7%$101.13M$23.50M0.00245News CoveragePositive NewsShort Interest ↓MBOTMicrobot Medical1.6259 of 5 stars$2.69+1.3%$9.00+235.2%+216.2%$97.68MN/A-4.1320News CoverageEarnings ReportFONRFonar2.466 of 5 stars$15.47+0.7%N/A-9.4%$95.96M$103.02M12.38480News Coverage Related Companies and Tools Related Companies Lakeland Industries Alternatives InfuSystem Alternatives Anteris Technologies Global Alternatives Biosig Technologies Alternatives Lucid Diagnostics Alternatives icad Alternatives Orchestra BioMed Alternatives Jin Medical International Alternatives Microbot Medical Alternatives Fonar Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PYPD) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolyPid Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PolyPid With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access